Search by Drug Name or NDC
NDC 51862-0339-01 Chlorzoxazone 500 mg/1 Details
Chlorzoxazone 500 mg/1
Chlorzoxazone is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mayne Pharma Commercial LLC. The primary component is CHLORZOXAZONE.
MedlinePlus Drug Summary
Chlorzoxazone is used to relieve pain and stiffness caused by muscle strains and sprains. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest.
Related Packages: 51862-0339-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Chlorzoxazone
Product Information
| NDC | 51862-0339 |
|---|---|
| Product ID | 51862-339_ffd326e9-a80a-275a-e053-6394a90a213a |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Chlorzoxazone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | chlorzoxazone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 500 |
| Active Ingredient Units | mg/1 |
| Substance Name | CHLORZOXAZONE |
| Labeler Name | Mayne Pharma Commercial LLC |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211849 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51862-0339-01 (51862033901)
| NDC Package Code | 51862-339-01 |
|---|---|
| Billing NDC | 51862033901 |
| Package | 100 TABLET in 1 BOTTLE (51862-339-01) |
| Marketing Start Date | 2020-07-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |